ACLY and metabolic dysfunction-associated steatotic liver disease: NAFLD as a systemic metabolic stress enhanced DNL in hepatocytes via multiple mechanisms, such as upregulating of USP14 to deubiquitinate FASN and promote its stability, and depleting SH3RF2 to stabilize ATP citrate lyase (ACLY) [59, 60].